Published Date: 02 Mar 2023
A study published online Feb. 27 in JAMA Internal Medicine found that interventions increase prevention but not the association with alcohol use disorder (AUD) in primary care.
Read Full NewsThree imaging-guided PCI trials (two with surprising results), LDL targets, an oral PCSK9 inhibitor, and another beta-blocker withdrawal trial are the topics John Mandrola, MD, discusses in this week’s podcast.
Conflict in the Gulf is exposing how dependent Europe’s pharmacies are on global supply chains for essential medicines, active ingredients, and transport.
Older adults with acute severe ulcerative colitis have higher mortality, underscoring the need for targeted strategies to reduce the risk for adverse events and enable timely treatment decisions.
Doctors aren't dietitians. Fantuzzi and Straughan unpack the flaws in the new HHS nutrition competencies and advocate for collaborative care.
U.S. Health Secretary Robert F. Kennedy Jr. on Thursday issued a new charter for a CDC vaccine advisory committee that expands the role of the panel to include a focus on...
Growing antimicrobial resistance is prompting renewed interest in phage therapy, with preliminary data indicating improved outcomes when combined with standard antibiotics.
Debate is growing over whether national policy decisions can meet the criteria for global health emergencies, as projections suggest major setbacks in infectious disease control.
1.
Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.
2.
Early palliative care billing up from 2010 to 2019 for advanced cancer
3.
AI catches one-third of interval breast cancers missed at screening
4.
GLP-1 receptor agonists show anti-cancer benefits beyond weight loss
5.
Surgeons are at higher risk of cancer, study suggests
1.
Gut microbiota in curing cancer
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice
4.
Precision Medicine and Genomics: Revolutionizing Healthcare Through Personalized Treatment
5.
Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation